Northpond Ventures GP, LLC's Form 4 filing
DICE Therapeutics, Inc. (DICE) · filed Jun 23, 2023
- Accession no.
- 0000899243-23-016413
- Filed
- Jun 23, 2023, 5:36 PM ET
- Trade date
- Jun 22, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $115.9M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Northpond Ventures GP, LLCCIK 0001867470 | 10% Owner |
| Northpond Ventures, LPCIK 0001867472 | 10% Owner |
| Rubin Michael P.CIK 0001867627 | 10% Owner |
| Northpond Ventures II GP, LLCCIK 0001869114 | 10% Owner |
| Northpond Ventures II, LPCIK 0001869128 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2023 | Common Stock | SSaleDisposed | −1,969,368 | $46.50 | −$91,575,612 | 633,707 | Indirect | |
| Jun 22, 2023 | Common Stock | SSaleDisposed | −523,503 | $46.50 | −$24,342,889.5 | 166,293 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.